Michael Rudnicki
10.1155/2017/2180508
Biomed Res Int
2017;2017:2180508.
CC BY
https://pubmed.ncbi.nlm.nih.gov/28573137/
Complement C3 / genetics Glomerulonephritis, Membranoproliferative / drug therapy Inflammation / drug therapy Rituximab / therapeutic use
Complement C3 / genetics Glomerulonephritis, Membranoproliferative / drug therapy Inflammation / drug therapy Rituximab / therapeutic use Review Cell Proliferation / drug effects Glomerular Basement Membrane / drug effects Glomerular Basement Membrane / pathology Glomerulonephritis, Membranoproliferative / genetics Glomerulonephritis, Membranoproliferative / pathology Humans Immunoglobulins / genetics Inflammation / genetics Inflammation / pathology Kidney Glomerulus / drug effects Kidney Glomerulus / pathology Remission Induction Complement C3 Immunoglobulins Rituximab
PMC5440792
28573137
Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies
2017